首页>
中文期刊>
《世界胃肠病学杂志:英文版》
>Bevacizumab plus infusional 5-fluorouracil,leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy:A pilot study
Bevacizumab plus infusional 5-fluorouracil,leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy:A pilot study
机译:改进的Xeliri(Capecitabine Plus Irinotecan)与Folfiri(Leucovorin,Fluyouracil和Irinotecan),无论是在还是没有bevacizumab,作为转移性结肠直肠癌的二线治疗(Axept):多期,开放标签,随机,非劣势 ,第3阶段试验